Roger Crystal, Chief Executive Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 10,058 shares at $20.20 ($203K) on 2023-01-05, disclosed to the SEC on 2023-01-05.
Seasonal sale ($203k) by Chief Executive Officer — this insider has traded OPNT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.20 | 5,029 | $102K | 50.0% |
| 2 | $20.20 | 5,029 | $102K | 50.0% |
| Total | $20.20 avg | 10,058 | $203K | 100% |
| Filing → |
| OPNT | SELL | 2022-07-15 | $25K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $104K | — | Filing → |
| OPNT | SELL | 2022-01-12 | $32K | — | Filing → |